Related Experiment Videos
[Vaccine development].
Kihei Terada1, Takahiro Niizuma
1Department of Pediatrics, Kawasaki Medical School.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 21, 2002
Summary
Advancements in vaccine technology, including gene technology, have led to new vaccines like subunit hepatitis B and rotavirus vaccines. Future developments focus on DNA and mucosal vaccines, with safety and cost being key considerations.
Area of Science:
- Vaccinology
- Molecular Biology
- Immunology
Context:
- Review of historical, current, and future vaccine development trends.
- Impact of gene technology on modern vaccine creation.
- Specific vaccine examples: Hepatitis B subunit, rotavirus recombinant, enhanced inactivated polio.
Purpose:
- To describe recent vaccine advancements and upcoming introductions in Japan.
- To highlight promising new vaccine technologies like DNA and mucosal vaccines.
- To emphasize the importance of safety, cost, and benefit analysis in vaccine research.
Summary:
- Gene technology has significantly advanced vaccine development, yielding subunit, recombinant, and enhanced inactivated vaccines.
- Emerging DNA and mucosal vaccines show promise but require careful evaluation of safety, cost, and benefits.
- Japan is set to introduce new vaccines, including MR/MMR and Hemophilus influenzae type b, with inactivated polio vaccine also pending approval.
Impact:
- Provides an overview of the evolving vaccine landscape, particularly in Japan.
- Informs researchers and policymakers about the potential and challenges of novel vaccine platforms.
- Highlights regulatory status of key vaccines for the Japanese market.